CD5 and breast neoplasm: To determine the level of CD5 among T cell subsets and within peripheral organs and tumor cells, mice subcutaneously implanted with syngeneic triple-negative 4T1 breast tumors were euthanized on day 21 after implantation and spleen, lymph nodes, and tumor tissue were harvested and processed to generate single cell suspensions containing immune cells.